Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in DCD Kidney Transplant Recipients: A Randomized, Open-label, Multicenter Clinical Trial

Trial Profile

Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in DCD Kidney Transplant Recipients: A Randomized, Open-label, Multicenter Clinical Trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jan 2019

At a glance

  • Drugs Tacrolimus (Primary) ; Corticosteroids; Mycophenolic acid
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma China
  • Most Recent Events

    • 31 Oct 2018 Status changed from not yet recruiting to recruiting.
    • 09 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Oct 2018.
    • 30 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top